Listed in Penny Stocks, Stock Picks, StockGuru.com, Day Trading, Best Stocks
Provectus Pharmaceuticals, Inc. (OTCBB: PVCT), a biopharmaceutical company focused on treating cancer and psoriasis using the Rose Bengal compound, similar to companies like Dendreon Corporation (Nasdaq: DNDN) and Human Genome Sciences (Nasdaq: HGSI), could be set to unlock significant value by going-it-alone with its PV-10 and PH-10 clinical trials.
Provectus Pharmaceuticals, Inc. (OTCBB: PVCT), a biopharmaceutical company focused on treating cancer and psoriasis using the Rose Bengal compound, could be set to unlock significant value by going-it-alone with its PV-10 and PH-10 clinical trials. While many other pharmaceutical companies typically partner early in the clinical trial process, Provectus has maintained control in a move that could give it significant leverage once approved by the U.S. Food and Drug Administration (FDA).
Late-Stage Trials Offer Increased Leverage
Penny Stocks are stocks traded for under $2 and they represent the small cap companies. They trade on the OTCBB so you will not find them on the major stock exchanges. They are very cheap stocks and normally come for businesses needing capital. They are a very risky investment as the business can go under and leave you with a stock worth nothing. However that being said penny stock trading can be a great money maker, and there are numerous traders who make 6 figures and more from them each year.
The best reasons to trade in penny stocks are the fact that they do not require a large initial investment, meaning that they are an affordable investment for many. Penny stocks are cheap. For example if you were to buy 1000 shares in a company with shares at 10 cents, you would only require an investment of $100, whereas if the shares cost $5 you would require an investment of $5000. Penny stocks also have the potential of huge gains, and have been known to rise as much as 1000% daily. Therefore your $100 investment can be worth $1000. This is very unlikely to happen to other stocks from large cap businesses.